Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF)
Not Applicable
Completed
- Conditions
- AsthmaChronic Obstructive Pulmonary Disease
- Interventions
- Device: Diskus inhalerDevice: Easyhaler type ADevice: Easyhaler type B
- Registration Number
- NCT01424137
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Brief Summary
The purpose of this study is to characterise inspiratory flow parameters across 2 Easyhaler® (EH) inhaler versions and Diskus® inhaler in patients with asthma (including children, adults, and the elderly) and in patients with chronic obstructive pulmonary disease (COPD).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 227
Inclusion Criteria
- Written informed consent (IC) obtained
- Documented diagnosis of asthma and/or COPD
- Age: 4 years and above
Read More
Exclusion Criteria
- Any severe chronic respiratory disease other than asthma or COPD
- Acute respiratory infection
- Any medical condition that in the opinion of the investigator would endanger the subject if he/she participates in the study
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Diskus inhaler Diskus inhaler - Easyhaler type A Easyhaler type A - Easyhaler type B Easyhaler type B -
- Primary Outcome Measures
Name Time Method Peak inspiratory flow rate through the placebo Easyhaler and Diskus inhalers 1 day
- Secondary Outcome Measures
Name Time Method The inspiratory volume through the placebo Easyhaler and Diskus inhalers will be measured at the same time with the peak inspiratory flow rate 1 day
Trial Locations
- Locations (5)
Tartu University Hospital, Lung Clinic
🇪🇪Tartu, Estonia
Turku University Hospital
🇫🇮Turku, Finland
Children's Clinic of Tartu, Allergy Centre
🇪🇪Tartu, Estonia
Jorvi Hospital HUS
🇫🇮Espoo, Finland
Lasnamäe Medicum
🇪🇪Tallinn, Estonia